By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Verona Pharma 

Suite 21 - Alpha House
100 Borough High Street
London    SE1 1LB  United Kingdom
Phone: 44-0-20-7863-3300 Fax: 44-0-20-7863-3314


SEARCH JOBS


Industry
Pharmaceutical

Segment
Life Sciences





Company News
Verona Pharma (VRP.L) Announces Positive Top-Line Data From Phase IIa Clinical Trial In COPD With RPL554 Dosed In Addition To Tiotropium (Spiriva) 9/7/2017 10:42:19 AM
Verona Pharma (VRP.L) Release: PDMR Dealing 8/21/2017 10:16:09 AM
Verona Pharma (VRP.L) Interim Results For The Six Months Ended June 30, 2017 And Clinical Development Update 8/8/2017 1:04:39 PM
Verona Pharma (VRP.L) To Announce Interim Results For Six Months Ended June 30, 2017 And Provide Clinical Development Update 8/2/2017 1:12:33 PM
Verona Pharma (VRP.L) Doses First Patients In Phase IIb Clinical Trial Of RPL554 For COPD Maintenance Treatment 7/26/2017 10:44:08 AM
Verona Pharma (VRP.L) Receives Regulatory Approval To Commence Phase IIb Clinical Trial Of RPL554 For COPD Maintenance Treatment In Five Countries Across Europe 6/27/2017 12:34:10 PM
Verona Pharma (VRP.L) Appoints Dr. Desiree Luthman As Vice President Of Regulatory Affairs 6/22/2017 11:00:38 AM
Verona Pharma (VRP.L) Initiates U.S. Clinical Pharmacokinetic Study For RPL554 Following Acceptance Of IND Application By FDA 6/5/2017 11:56:09 AM
Verona Pharma (VRP.L) Announces Closing Of Exercise Of Underwriters’ Over-Allotment Option 5/19/2017 7:54:28 AM
Verona Pharma (VRP.L) Announces Closing Of Global Offering 5/3/2017 11:11:55 AM
12345678
//-->